CAS 171596-29-5
:Tadalafil
- (6R,12Ar)-6-(1,3-Benzodioxol-5-Yl)-2,3,6,7,12,12A-Hexahydro-2-Methyl-Pyrazino[1',2':1,6]Pyrido[3,4-B]Indole-1,4-Dione
- (6R,12aR)-2,3,6,7,12,12a-hexahydro-2-methyl-6-(3,4-methylenedioxyphenyl)pyrazino[1′,2′:1,6]pyrido[3,4-b]indole-1,4-dione
- (6R,12aR)-6-(1,3-Benzodioxol-5-yl)-2,3,6,7,12,12a-hexahydro-2-methylpyrazino[1′,2′:1,6]pyrido[3,4-b]indole-1,4-dione
- (6R,12aR)-6-(1,3-benzodioxol-5-yl)-2-methyl-2,3,6,7,12,12a-hexahydropyrazino[1',2':1,6]pyrido[3,4-b]indole-1,4-dione
- (6R,12aR)-6-(1,3-benzodioxol-5-yl)-2-methyl-3,4,6,6a,7,11b,12,12a-octahydropyrazino[1',2':1,6]pyrido[3,4-b]indol-1(2H)-one
- Adcirca
- Cialis
- Gf 196960
- Ic-351
- Icos 351
- Lifta
- Pentadafil
- Pyrazino[1′,2′:1,6]pyrido[3,4-b]indole-1,4-dione, 6-(1,3-benzodioxol-5-yl)-2,3,6,7,12,12a-hexahydro-2-methyl-, (6R,12aR)-
- Pyrazino[1′,2′:1,6]pyrido[3,4-b]indole-1,4-dione, 6-(1,3-benzodioxol-5-yl)-2,3,6,7,12,12a-hexahydro-2-methyl-, (6R-trans)-
- Tadalafil Lilly
- Tadanafil
- Tadfil
- Tadora
- Talmanco
- Tardenafil
- Tildenafil
- Uk 336017
- Voir plus de synonymes
Tadalafil
CAS :Formule :C22H19N3O4Degré de pureté :>98.0%(T)(HPLC)Couleur et forme :White to Light yellow powder to crystalMasse moléculaire :389.41Tadalafil
CAS :Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormule :C22H19N3O4Couleur et forme :White Off-White PowderMasse moléculaire :389.13756(6R,12aR)-6-(Benzo[d][1,3]dioxol-5-yl)-2-methyl-2,3,12,12a-tetrahydropyrazino[1',2':1,6]pyrido[3,4-b]indole-1,4(6H,7H)-dione
CAS :Formule :C22H19N3O4Degré de pureté :95%Couleur et forme :SolidMasse moléculaire :389.4040Ref: IN-DA0037XA
1g24,00€5g31,00€10g47,00€1kg544,00€25g63,00€50g117,00€5kgÀ demander100g167,00€10kgÀ demander250g285,00€500g513,00€50mg24,00€Tadalafil
CAS :Tadalafil (IC-351) is a carboline-based compound with vasodilatory activity.Formule :C22H19N3O4Degré de pureté :97.03%Couleur et forme :Off-White Cyrstalline SolidMasse moléculaire :389.40Tadalafil
CAS :Formule :C22H19N3O4Degré de pureté :≥ 98%Couleur et forme :White to light-yellow powderMasse moléculaire :389.40Tadalafil
CAS :Formule :C22H19N3O4Couleur et forme :White To Off-White SolidMasse moléculaire :389.41Tadalafil
CAS :Produit contrôléStability Unstable in Methanol
Applications Tadalafil is used for the treatment of erectile dysfunction. A phosphodiesterase 5 inhibitor.
References Carrier, S., et al.: Can. J. Urol., 10(1), 12 (2003); Doggrell, S.A., et al.: Expert Opin. Pharmacother., 6, 75 (2005); Forgue, S.T., et al.: Br. J. Clin. Pharmacol., 61, 280 (2005);Formule :C22H19N3O4Couleur et forme :White To Off-WhiteMasse moléculaire :389.4Tadalafil - Bio-X ™
CAS :Tadalafil is a phosphodiesterase (PDE) inhibitor used to treat erectile dysfunction. It works by inhibiting the enzyme PDE, which is responsible for breaking down cGMP, a molecule that relaxes smooth muscle cells in the penis and allows for increased blood flow. Tadalafil has an ability to also act as a channel inhibitor and nerve growth factor inhibitor. Additionally, it is said to aid with pulmonary arterial hypertension by relaxing the blood vessels in the lungs to allow blood to flow more easily.Formule :C22H19N3O4Degré de pureté :Min. 95%Couleur et forme :PowderMasse moléculaire :389.4 g/molTadalafil-13C2,d3
CAS :Produit contrôléApplications Tadalafil-13C2,d3 is labelled Tadalafil (T004500) which is used for the treatment of erectile dysfunction. It is a phosphodiesterase 5 inhibitor.
References Carrier, S., et al.: Can. J. Urol., 10(1), 12 (2003), Doggrell, S.A., et al.: Expert Opin. Pharmacother., 6, 75 (2005), Forgue, S.T., et al.: Br. J. Clin. Pharmacol., 61, 280 (2005)Formule :C2013C2H16D3N3O4Couleur et forme :White PowderMasse moléculaire :394.412-Triethylmethyl Tadalafil
CAS :Produit contrôléFormule :C27H29N3O4Couleur et forme :NeatMasse moléculaire :459.537Tadalafil
CAS :Tadalafil is a phosphodiesterase type 5 inhibitor that is used to treat erectile dysfunction by increasing blood flow to the penis. It is an oral drug that blocks the enzyme phosphodiesterase type 5 (PDE5) and increases the levels of cyclic guanosine monophosphate (cGMP) in smooth muscle cells, leading to vasodilation and increased blood flow. Tadalafil has been shown to be effective in men with pulmonary hypertension and primary pulmonary hypertension. Tadalafil also has a side-effect profile similar to other PDE5 inhibitors, including headache, dizziness, nausea, nasal congestion or runny nose, indigestion, diarrhea or constipation, back pain and muscle pain. This drug also interacts with drugs that can cause serious adverse effects if taken with PDE5 inhibitors. Tadalafil is not active against bacteria; therefore it cannot be used for the treatment of bacterial infections such as tuberculosis.
Formule :C22H19N3O4Degré de pureté :(Hplc) Min. 98%Couleur et forme :White PowderMasse moléculaire :389.4 g/mol













